Arvin Abraham, Goodwin Procter LLP Partner, practices Private Equity

Arvin Abraham

Partner
Arvin Abraham
London
+44 (0) 7554 428 744

Arvin Abraham is a partner in Goodwin’s Private Equity group and co-chairs the firm’s European Healthcare and Fintech practices.

Recognised by Chambers and Partners and Legal 500 as a leading lawyer for Healthcare and Fintech transactions, clients praise his “ability to think many steps ahead, simplify complex issues and offer practical solutions,” as well as his “excellent client service, commercial instinct and technical skill.”

Arvin advises private equity sponsors, growth investors and innovative companies – bridging legal, strategic and commercial perspectives to help clients navigate transactions and build long-term value.

Representative Matters

  • Advising TA Associates on numerous healthcare private equity matters, including the sale of a stake in BioComposites to Novo Holdings
  • Advising Level Equity on its purchase of Sora Risk Solutions
  • Advising an undisclosed seller on the sale of its stake in Oak North to Affinity Partners
  • Advising Accelex on its sale to Carta
  • Advising Mosaic Smart Data on its sale to Behavox
  • Advising Clermont on the sale of its interests in The Medical City to CVC
  • Advising HIG and its portfolio company Milestone Technologies on the purchase of Paysafe India*
  • Advising Datacore Software on the purchase of Object Matrix*
  • Advising Carlyle on its acquisition of ExamWorks*
  • Advising Wellspring on its acquisition of Caring Brands*
  • Advising Credit Suisse in purchasing the EMEA private wealth management business of Morgan Stanley*
  • Advising Towergate Insurance plc. in its restructuring and asset sale pursuant to a scheme of reorganization*
  • Advising J.C. Flowers & Co. in an auction process to acquire a UK based financial services company*
  • Advising Lightyear Capital in a co-investment in a UK reinsurer*

*Denotes experience prior to joining Goodwin.

  • Advising Fundment on its Series C Financing led by Highland Capital
  • Advising Hologen on its Seed financing led by Anomaly Ventures
  • Advising Six Degrees Capital on its investments into Paggo Technologies, Conveo and Uvicuo
  • Advising Illuminate on its investment into Fuse Group
  • Advising Bank Muscat on its investment into Zopa Bank
  • Advising Helios on its investment into Moment
  • Advising Framework on its investment into Odin Silver
  • Advising HSBC on the formation of the HSBC Financial Technology Venture Capital Fund*
  • Advising HSBC on its Series A investment into TAINA Technology Limited, its Series C and Series C Plus investments into Quantifeed Holdings Limited, and its Series A investment into Better Trade Off*
  • Advising Hoxton Ventures on its Pre-Seed investments into BeyondRisk, Fabrica Robotics, and Poetics AI*
  • Advising Premier Healthcare on its Series A investment into DGHE*
  • Advising the Clermont Group on its Series A investment into Post Era, Inc.*
  • Advising Fidelity International Strategic Ventures on its Series C Plus investment into Quantifeed Holdings Limited*
  • Advising Deutsche Bank on its Series A investment into TAINA Technology Limited*
  • Advising Boxabl on its Europe and Asia crowdfunding efforts and a variety of other transactional matters*
  • Advising Third Time on its Seed funding round including a simultaneous equity and token warrant issuance*

*Denotes experience prior to joining Goodwin.

  • Advising CEX.io on regulatory issues in connection with its acquisition of Currency.com
  • Advising Savea on the issuance of a tokenized wine fund
  • Advising on the formation of the FAST-Infra Bank Consortium*
  • Advising Credit Saison on the formation of its Web 3 investment business*
  • Advising Third Time Games on US crypto regulatory issues*
  • Advising Meta on the transition of Facebook and Instagram to NFT minting platforms*
  • Advising Animoca Brands on UK and EU crypto regulatory issues relating to in-game tokens including for its EDU, GMEE, QUIDD, REVV and TOWER products*
  • Advising various clients on institutional crypto custody and trading arrangements*
  • Advising Ripple on a potential partnership with a stablecoin issuer*
  • Advising Agoric Systems on a crypto liquidity lending agreement*
  • Advising Lemonade on UK regulatory issues associated with a new crypto insurance product*
  • Advising FQX AG on UK regulatory issues relating to its platform for e-promissory notes*

*Denotes experience prior to joining Goodwin.

Professional Activities

Arvin serves on the Bank of England’s C-Suite Central Bank Digital Currency Working Group.

Professional Experience

Prior to joining Goodwin, Arvin was a partner with McDermott, Will & Emery in London where he was co-chair of the FinTech & Blockchain practice. Between 2015 and 2020 Arvin worked in management roles at Morgan Stanley and HSBC.

Credentials

Education

JD2009

Harvard Law School

(magna cum laude)

LLMCommercial Law2008

University of Cambridge

BABusiness Economics2005

University of California, Los Angeles

(summa cum laude)

Admissions

Bars

  • New York
  • England and Wales

Recognition & Awards

  • Ranked in Private Equity: Transactions Mid-Market Deals, Legal 500 UK, 2022-2024
  • Recommended Individual: Fintech, Legal 500 UK, 2023-2024
  • Ranked in FinTech Legal – Blockchain & Cryptocurrencies, Chambers UK 2022-2024
  • Ranked in FinTech Legal – Corporate Securities & Financing, Chambers UK 2022-2024

Publications / Speaking / Press

Arvin’s recent publications include:

  • “5 Fintech Predictions for 2024: A Light at the End of the Tunnel,” Finextra, February 2024
  • “Assessing the CFTC’s Lawsuit Against Binance,” Finextra, April 2023
  • Co-Author, “Crypto Exchanges in Crisis – Acquisition and Restructuring Opportunities,” Global Turnaround, March 2023 
  • Author, “5 Predictions for FinTech in 2023,” Finextra, January 2023
  • Author, “Navigating a Distressed FinTech Market,” Finextra, October 2023
  • “Law & Order in the Metaverse,” Finextra, April 2022
  • Contributor, “MiCA Opportunities and Risks for Investors,” Real Deals, March 2021
  • “Demystifying DAOs,” Finextra, October 2021

Arvin’s recent speaking engagements include:

  • Moderator, “MedTech and HealthTech in Focus” September 2025
  • Moderator, “A New Dawn – Hot Topics in FinTech”, February 2025
  • Speaker, “Fintech in Focus: Maximizing Value in a Challenging Funding Environment,” February 2023
  • Speaker, “Digital Currency & Blockchain – Regulatory Perspectives from Both Sides of the Pond”, November 2023
  • Speaker, “Time for the Digital Pound - is a CBDC right for the UK?,” BVCA High Growth Conference, June 2023
  • Speaker, “London Tech Week: Navigating Regulation & Political Winds for Cryptoassets,” June 2023
  • Moderator, “Staying Ahead of the Curve: The Future of FinTech and Crypto Regulation,” April 2023 
  • Moderator, “She Loves Tech Global Conference in Singapore: Debate – Women Are Not an Impact Investment,” November 2022
  • Speaker, “Navigating CBDC Unknowns,” Finextra Digital Assets Series, July 2022
  • Speaker, “Catch me If You Can: Compliance Chases Crypto,” March 2022

Arvin’s recent press includes:

  • “A Lawyer Who Understands Fintech”, the Banker, November 2023